| 詳細情報 |   |
|---|---|
| 関連リンク |  |
| 探す |  |
論文 (370件)
- Yuhan Rong, Ikuma Kato, Naoki Okubo, Sho Tsuyuki, Eriko Katsuta, Noritoshi Kobayashi, Kazuya Nakagawa, Mayumi Ozawa, Jun Watanabe, Atsushi Ishibe, et al. Potential neuroendocrine differentiation in poorly differentiated colorectal adenocarcinoma: A hidden trait?. Molecular and clinical oncology. 2024. 21. 6. 91-91
- Yusuke Kurita, Daisuke Utsunomiya, Kensuke Kubota, Shingo Koyama, Sho Hasegawa, Kunihiro Hosono, Kuniyasu Irie, Yuichi Suzuki, Shin Maeda, Noritoshi Kobayashi, et al. Diagnostic Value of Contrast-Enhanced Dual-Energy Computed Tomography in the Pancreatic Parenchymal and Delayed Phases for Pancreatic Cancer. Tomography (Ann Arbor, Mich.). 2024. 10. 10. 1591-1604
- Motokazu Sato, Toshihiko Sato, Chihiro Hozumi, Qinghong Han, Kohei Mizuta, Sei Morinaga, Byung Mo Kang, Noritoshi Kobayashi, Yasushi Ichikawa, Atsushi Nakajima, et al. [11C]Methionine PET vs. [18F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients. Anticancer Research. 2024. 44. 9. 3891-3898
- Motokazu Sato, Qinghong Han, Chihiro Hozumi, Hideo Kujiraoka, Kohei Mizuta, Sei Morinaga, Byung Mo Kang, Noritoshi Kobayashi, Yasushi Ichikawa, Atsushi Nakajima, et al. First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease. Anticancer Research. 2024. 44. 9. 3885-3889
- Motokazu Sato, Qinghong Han, Chihiro Hozumi, Hideo Kujiraoka, Kohei Mizuta, Sei Morinaga, Byung Mo Kang, Noritoshi Kobayashi, Yasushi Ichikawa, Atsushi Nakajima, et al. First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease. Anticancer research. 2024. 44. 9. 3885-3889
- Motokazu Sato, Toshihiko Sato, Chihiro Hozumi, Qinghong Han, Kohei Mizuta, Sei Morinaga, Byung Mo Kang, Noritoshi Kobayashi, Yasushi Ichikawa, Atsushi Nakajima, et al. [11C]Methionine PET vs. [18F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients. Anticancer research. 2024. 44. 9. 3891-3898
- Sho Sato, Takashi Suzuki, Takashi Chinen, Hironori Yamaguchi, Yusuke Suzuki, Nobukazu Hokamura, Zenichiro Saze, Koji Kono, Keita Takahashi, Fumiaki Yano, et al. Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases. Journal of gastroenterology. 2024
- Yutaro Takahashi, Takayoshi Iijima, Yumi Ishidera, Yuichi Imai, Taichi Mizushima, Daisuke Utsunomiya, Noritoshi Kobayashi, Yasushi Ichikawa, Shingo Kato, Jotaro Harada, et al. Primary Small Bowel Adenocarcinoma with Metastatic Ovarian Tumor in a Pregnant Woman. Case Reports in Oncology. 2024. 17. 1. 882-890
- Atsushi Yamamoto, Takaomi Kessoku, Tomoki Ogata, Tsumugi Jono, Kota Takahashi, Kosuke Tanaka, Ko Suzuki, Yuma Takeda, Anna Ozaki, Yuki Kasai, et al. A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care Setting. Diagnostics (Basel, Switzerland). 2024. 14. 15
- Motokazu Sato, Qinghong Han, Kohei Mizuta, Ryosuke Mori, Byung Mo Kang, Sei Morinaga, Noritoshi Kobayashi, Yasushi Ichikawa, Atsushi Nakajima, Robert M. Hoffman. Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet. In Vivo. 2024. 38. 3. 1459-1464
- Motokazu Sato, Kohei Mizuta, Qinghong Han, Sei Morinaga, Byung Mo Kang, Yutaro Kubota, Ryosuke Mori, Anton Baranov, Keita Kobayashi, Daniel Ardjmand, et al. Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model. In Vivo. 2024. 38. 3. 1058-1063
- Sho Sato, Takashi Ssuzuki, Takashi Chinen, Hironori Yamaguchi, Yusuke Suzuki, Nobukazu Hokamura, Zenichiro Saze, Koji Kono, Keita Takahashi, Fumiaki Yano, et al. The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study. International journal of clinical oncology. 2024
- Motokazu Sato, Qinghong Han, Ryosuke Mori, Kohei Mizuta, Byung Mo Kang, Sei Morinaga, Noritoshi Kobayashi, Yasushi Ichikawa, Atsushi Nakajima, Robert M. Hoffman. Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet. Anticancer Research. 2024. 44. 4. 1499-1504
- Motokazu Sato, Qinghong Han, Ryosuke Mori, Kohei Mizuta, Byung Mo Kang, Sei Morinaga, Noritoshi Kobayashi, Yasushi Ichikawa, Atsushi Nakajima, Robert M Hoffman. Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet. Anticancer research. 2024. 44. 4. 1499-1504
- 高橋 宏太, 栗田 裕介, 小林 規俊, 中島 淳, 市川 靖史. 膵神経内分泌腫瘍に対する,エベロリムスの治療効果に与えるPRRTの影響について. 日本消化器病学会雑誌. 2024. 121. 臨増総会. A409-A409
- Shoko Ohashi, Daisuke Takakura, Noritoshi Kobayashi, Motohiko Tokuhisa, Yasushi Ichikawa, Nana Kawasaki. Comparative Analysis of Site-Specific N-glycosylation of LAMP1 from Breast Cancer Tissues. Journal of biochemistry. 2024
- Motokazu Sato, Qinghong Han, Kohei Mizuta, Ryosuke Mori, Byung Mo Kang, Sei Morinaga, Noritoshi Kobayashi, Yasushi Ichikawa, Atsushi Nakajima, Robert M Hoffman. Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet. In vivo (Athens, Greece). 2024. 38. 3. 1459-1464
- Motokazu Sato, Kohei Mizuta, Qinghong Han, Sei Morinaga, Byung Mo Kang, Yutaro Kubota, Ryosuke Mori, Anton Baranov, Keita Kobayashi, Daniel Ardjmand, et al. Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model. In vivo (Athens, Greece). 2024. 38. 3. 1058-1063
- Yutaro Takahashi, Takayoshi Iijima, Yumi Ishidera, Yuichi Imai, Taichi Mizushima, Daisuke Utsunomiya, Noritoshi Kobayashi, Yasushi Ichikawa, Shingo Kato, Jotaro Harada, et al. Primary Small Bowel Adenocarcinoma with Metastatic Ovarian Tumor in a Pregnant Woman. Case reports in oncology. 2024. 17. 1. 882-890
- Motokazu Sato, Qinghong Han, Yutaro Kubota, Anton Baranov, Daniel Ardjmand, Kohei Mizuta, Sei Morinaga, Byung Mo Kang, Noritoshi Kobayashi, Michael Bouvet, et al. Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer. Anticancer research. 2024. 44. 1. 31-35
前のページに戻る
